دورية أكاديمية

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.

التفاصيل البيبلوغرافية
العنوان: Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.
المؤلفون: Vanassche, T., Engelen, M. M., Van Thillo, Q., Wauters, J., Gunst, J., Wouters, C., Vandenbriele, C., Rex, S., Liesenborghs, L., Wilmer, A., Meersseman, P., Van den Berghe, G., Dauwe, D., Verbeke, G., Thomeer, M., Fivez, T., Mesotten, D., Ruttens, D., Heytens, L., Dapper, I.
المصدر: Trials; 12/29/2020, Vol. 21 Issue 1, p1-2, 2p, 2 Diagrams
مصطلحات موضوعية: COVID-19, CLINICAL trials, DRUG labeling
مستخلص: An amendment to this paper has been published and can be accessed via the original article. [ABSTRACT FROM AUTHOR]
Copyright of Trials is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17456215
DOI:10.1186/s13063-020-04991-y